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The epidermal growth factor receptor (EGFR/ERB1) plays a key role in the regulation of 
epithelial cell development, differentiation and in the pathophysiology of 
hyperproliferative diseases such as cancer. Transactivation of the EGFR/ERB1 by G-
protein coupled receptors has been shown to be dependent on proteolytic cleavage of 
membrane ligands such as heparin binding epidermal growth factor (HBEGF), EGF, 
transforming growth factor α (TGF-α), epiregulin, amphiregulin and betacellulin. Utilizing 
the human submandibular gland (HSG) cell line, we found that activation of the P2Y2 
nucleotide receptor (P2Y2R) by its agonist UTP caused a time-dependent activation of 
EGFR/ERB1; however, neutralizing antibodies to the known ligands to EGFR/ERB1 
failed to inhibit the UTP-induced phosphorylation of EGFR/ERB1. EGFR/ERB1 
phosphorylation can also be induced by heterodimerization with one of the other ERB 
family members, ERB2, ERB3, and ERB4. HSG cells express ERB2 and ERB3 but not 
ERB4. Since ERB2 is a ligandless receptor, ERB3 is the likely dimerizing partner. Our 
results indicate that P2Y2R activation by UTP phosphorylates ERB3. Heregulin, the only 
known ligand for ERB3 is expressed in HSGs. Therefore, our results suggest that 
P2Y2R activation stimulates the formation of ERB3-EGFR/ERB1 heterodimers by 
cleavage of heregulin and its binding to ERB3.
 
